Trade Name

Bilazap

Request Type

New Registration

Drug Type

Generic(Multisource) Drug

Approval Date

اثنين, 12/01/2025 - 12:00

SFDA Approved Use

Symptomatic treatment of allergic rhinoconjunctivitis (seasonal and perennial) and urticaria.
Bilastine 20 mg tablets is used in adults and adolescents (12 years and older).